Extracellular domain of kinase domain region mediated by adeno-associated virus inhibits growth and angiogenesis of bladder cancer in Balb-c mice

Chinese Medical Journal

Volumn 115, Issue 8, 2002, Pages 1209-1212

  Zhang, Zhichao ^a,b,c   Zhang, Zhiqing ^a   Zeng, Gefei ^a   Zhang, Liguo ^a   Xu, Chunxiao ^a   Guo, Yinglu ^a  

^a PEKING UNIVERSITY   (China)

^b National Laboratory of Molecular Virology and Genetic Engineering   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Adeno associated virus; Bladder cancer; Receptor; Vascular endothelial growth factor

Indexed keywords

COMPLEMENTARY DNA; TYROSINE KINASE RECEPTOR; VIRUS VECTOR; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SIZE; CELL CULTURE; CONTROLLED STUDY; EXTRACELLULAR SPACE; GENETIC TRANSFECTION; HAMSTER; HELPER VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; MICROVASCULATURE; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT; ANIMAL; BAGG ALBINO MOUSE; BLADDER TUMOR; FEMALE; GENE THERAPY; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

ANIMAL; BLADDER NEOPLASMS; CLONING, MOLECULAR; DEPENDOVIRUS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE THERAPY; HAMSTERS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; SUPPORT, NON-U.S. GOV'T; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ANIMALS; CRICETINAE; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036674460     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Vascular endothelial growth factor
2. Vascular permeability factor (VPF, VEGF) in tumor biology
3. Identification of a new endothelial cell growth factor receptor tyrosine kinase
4. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
5. Adeno-associated virus-based vectors in gene therapy
6. Construction of a series of adeno-associated virus vectors and their expression of β-galactosidase gene
7. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
8. The biology of vascular endothelial growth factor
9. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
10. 121 cDNA transfection on angiogenesis and metastasis of human lung giant cell carcinoma
11. Suppressing of tumor angiogensesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ
12. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
13. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate